Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,787 public trials 2,088 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Recruiting

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

NCT06912087

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +12 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Recruiting

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

NCT06248554

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China Wuhan, China

View Trial Details

Recruiting

Decision Aid (DA) for Renal Patients

NCT05387863

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: NYU Langone Health New York, United States

View Trial Details

Recruiting

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

NCT07258979

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

Zhangzhou Municiple Hospital of Fujian Province Zhangzhou, Fujian, China

View all 20 locations

View Trial Details

Recruiting

Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT06576973

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Recruiting

HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors

NCT06515314

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

NCT06440993

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
Locations: Uniklinik RWTH Aachen Aachen, Germany

Universitätsklinikum Bonn Bonn, Germany

Universitätsklinikum Köln Cologne, Germany

Universitätsklinikum Düsseldorf Düsseldorf, Germany

View Trial Details

Recruiting

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

NCT07157969

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

International Multicentric Study ARON-1

NCT05287464

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Ospedale di Macerata, UOC Oncologia Province of Macerata, Macerata, Italy

View Trial Details

Recruiting

National Liver Cancer Screening Trial

NCT06084234

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +22 more
Locations: University of Southern California Los Angeles, California, United States

Stanford University Redwood City, California, United States

Kaiser Permanente Roseville, California, United States

University of California, San Francisco San Francisco, California, United States

View all 18 locations

View Trial Details